Last $0.45 USD
Change Today 0.00 / 0.00%
Volume 0.0
BRTX On Other Exchanges
As of 8:10 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

biorestorative therapies inc (BRTX) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/30/14 - $0.75
52 Week Low
06/25/14 - $0.24
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

biorestorative therapies inc (BRTX) Related Businessweek News

No Related Businessweek News Found

biorestorative therapies inc (BRTX) Details

BioRestorative Therapies, Inc., a development stage company, develops medical procedures using cell and tissue protocols, primarily involving adult stem cells that are designed for patients to undergo minimally invasive cellular-based treatments. The company is involved in the development of the ThermoStem Program that focuses on the treatment for type 2 diabetes, obesity, hypertension, other metabolic disorders, and cardiac deficiencies. It also focuses on the development of brtxDISC Program that is designed to offer a non-surgical cellular therapy for the treatment and relief of protruding, bulging, and herniated discs. In addition, the company offers stem cell derived cosmetic and skin care products under the Stem Pearls brand; and develops a human adult stem cell-derived extract that, when applied to human skin cells, enhances the production of collagen and fibronectin for combating the aging of skin. It has a research and development agreement with Rohto Pharmaceutical Co., Ltd. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York.

3 Employees
Last Reported Date: 04/11/14
Founded in 1997

biorestorative therapies inc (BRTX) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $360.0K
Vice President of Operations and Secretary
Total Annual Compensation: $118.0K
Vice President of Research & Development
Total Annual Compensation: $230.0K
Compensation as of Fiscal Year 2013.

biorestorative therapies inc (BRTX) Key Developments

BioRestorative Therapies Deleted From OTCBB

BioRestorative Therapies, Inc.’s common stock has been deleted from OTC Bulletin Board effective July 17, 2014 on account of its ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11.

Joel San Antonio Resigns as Director of Biorestorative Therapies, Inc

On June 27, 2014, Joel San Antonio resigned as a director of BioRestorative Therapies, Inc. due to other business commitments.

BioRestorative Therapies Appoints Joseph B. Swiader to Its Board of Directors

BioRestorative Therapies, Inc. announced the appointment of Joseph B. Swiader to its Board of Directors. Mr. Swiader will chair the Nominating Committee and serve on the Compensation Committee of the Board. He is currently managing partner of Wet Earth Partners LLC, which he founded in 2002.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRTX:US $0.45 USD 0.00

BRTX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Athersys Inc $2.19 USD +0.083
Cytori Therapeutics Inc $0.48 USD -0.004
IntelliCell BioSciences Inc $0.0002 USD 0.00
StemCells Inc $1.07 USD 0.00
Vericel Corp $3.10 USD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation BRTX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 36.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 23.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIORESTORATIVE THERAPIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at